- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
The head of the World Health Organization says more than 100,000 confirmed cases of coronavirus have been reported...
Read More
Read More
The US Food and Drug Administration on Monday revoked its emergency use authorisation for hydroxychloroquine to treat...
Read More
Read More
As India looks to ramp up testing to deal with the surge in coronavirus infections, a Korean company’s antigen test...
Read More
Read More
VisusNano was awarded the funding for its drug-eluting MEDILens product, which is being developed to release...
Read More
Read More
The U.S. government has shelled out big money to help develop a possible COVID-19 vaccine and boost manufacturing of...
Read More
Read More
If there is one drug countries around the world need the most to cope with the coronavirus, it is paracetamol. A...
Read More
Read More
Beximco Pharmaceuticals to give drug, which has been authorised by the US for emergency use in the treatment of...
Read More
Read More
A recent virtual event organised by CorpGini, on ‘The Future of Healthcare, Pharma and Allied Industries’ witnessed...
Read More
Read More
A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt. ...
Read More
Read More
India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead...
Read More
Read More
The country’s pharma plants have continued to run through the nationwide lockdown, and now a few cases of employees...
Read More
Read More
There is an opportunity for the Indian pharmaceutical industry to play a larger role in global drug...
Read More
Read More